Physician

Himmat S. Gill, M.D.

According to 2025 Medicare claims, Himmat Gill, M.D. (NPI: 1891728838) practices rheumatology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is HIMMAT S GILL MD INC (NPI: 1306024849; TIN: 261674115) and primary practice location at 93720-1832.

Gill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,386 traditional Medicare patients, billed 329,739 HCPCS/CPT codes, and received $4,431,024 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,965 prescription claims across 589 beneficiaries totaling $5,256,263 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 98 records totaling $2,592. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,084,816 to $4,431,024. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,843,392 to $5,256,263. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	540	95,146	$1,084,816
2016	647	105,968	$1,523,514
2017	777	113,543	$1,758,279
2018	934	120,446	$2,288,803
2019	904	133,296	$2,466,546
2020	831	114,333	$2,142,755
2021	911	131,783	$2,245,295
2022	1,076	185,604	$2,210,177
2023	1,368	254,713	$3,280,056
2024	1,386	329,739	$4,431,024

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	518	5,239	$1,843,392
2016	565	5,078	$2,639,869
2017	587	4,862	$2,639,272
2018	669	5,271	$3,480,560
2019	667	5,439	$3,814,933
2020	633	5,239	$3,671,015
2021	639	4,923	$3,919,936
2022	601	4,287	$5,053,135
2023	601	4,072	$5,829,136
2024	589	3,965	$5,256,263

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	382	872	$92
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	758	2,174	$58
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	252	266	$47
J0897	Injection, denosumab, 1 mg	653	63,720	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	332	602	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	245	7,256	$1,889,996
Humira(Cf) Pen	Adalimumab	152	4,368	$1,040,181
Rinvoq	Upadacitinib	82	2,700	$560,448
Orencia Clickject	Abatacept	50	1,400	$280,187
Cimzia (2 Pack)	Certolizumab Pegol	33	924	$182,569

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	98	$2,592	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Himmat S. Gill, M.D.?

Tedicare shows public-source Medicare data for Himmat S. Gill, M.D. (NPI 1891728838), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Himmat S. Gill, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Himmat S. Gill, M.D.?

Himmat S. Gill, M.D. is linked to HIMMAT S GILL MD INC (billing NPI 1306024849) in the available physician profile data.

Does Himmat S. Gill, M.D. have Open Payments data?

Himmat S. Gill, M.D. has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.